PUBLISHER: SkyQuest | PRODUCT CODE: 1322021
PUBLISHER: SkyQuest | PRODUCT CODE: 1322021
Spinal Cord Stimulation Market size was valued at USD 3.02 billion in 2021 and is poised to grow from USD 3.25 billion in 2022 to USD 5.83 billion by 2030, growing at a CAGR of 7.58% in the forecast period (2023-2030).
The spinal cord stimulator (SCS), also known as the dorsal column stimulator, is a neurostimulation device implanted in the body to treat chronic pain. It works by emitting electric signals that block pain signals, providing relief for conditions related to the spinal cord, back, arms, and legs. This therapy is particularly beneficial for patients with chronic pain who have not responded to medication or other traditional treatments.
The global SCS market is experiencing significant growth due to advancements in technology, the establishment of guidelines for SCS procedures, and the increasing adoption of minimally invasive therapies. These factors are driving the attention and demand for SCS globally. Additionally, the high prevalence of chronic pain in the population, attributed to sedentary lifestyles, further contributes to the market's expansion. The current boom in the market is expected to create more opportunities in the future, fueled by the growing adoption of neurostimulation techniques.
Segments covered in this report
Spinal Cord Stimulation Market segmentation is based on technology type, application and region. Based on technology type the market is segmented into rechargeable and non- rechargeable types. Based on application, the market is segregated into failed back surgery syndrome, complex regional pain syndrome, arachnoiditis, sciatica, degenerative disc disease and others. Based on region the Spinal Cord Stimulation Market is segmented into North America, Europe, Asia-Pacific and Rest of the world
Driver
Continuous technological advancements and government guidelines are driving the growth of the spinal cord stimulator market. Manufacturers are focusing on making devices smaller and more efficient, leading to the development of more advanced impulse production. Additionally, government associations are establishing recommendations and guidelines for the use of spinal cord stimulation therapy in treating chronic pain and other conditions. These guidelines, such as those released by the National Institute for Health and Care Excellence, are encouraging market activity and adoption of spinal cord stimulators.
Restraint
The high costs associated with spinal cord stimulator implantation and the uneven distribution of medical services are posing challenges to market growth. The surgery costs can vary significantly depending on factors such as insurance coverage and out-of-pocket expenses. Additionally, the ongoing maintenance expenses and replacement costs further contribute to the financial burden for patients. Moreover, the lack of availability of healthcare equipment in remote locations limits treatment options for the local population, leading to a dependency on larger towns for necessary medical care. These factors are likely to impede the growth of the market.
Market Trends
Government initiatives aimed at reducing opioid dependence have led to an increased demand for alternative therapies, including spinal cord stimulation devices. Governments in the U.S., Europe, and other countries are actively supporting the development and approval of non-opioid pain management devices. Medical device companies like Medtronic, Abbott, and Boston Scientific are investing in research and development to capitalize on this growing market opportunity.
Technological advancements in the field of spinal cord stimulation are also driving market growth. Miniature devices are being developed, and customization techniques such as remote-control options, rechargeable batteries, and wireless connectivity are being incorporated into the devices. These advancements allow for more personalized and convenient treatment options in the healthcare sector.